Home Other Building Blocks 2-(1H-Imidazol-2-yl)-pyrimidine

2-(1H-Imidazol-2-yl)-pyrimidine

CAS No.:
627910-87-6
Catalog Number:
AG00EFK5
Molecular Formula:
C7H6N4
Molecular Weight:
146.1493
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
97%
1 week
United States
$266
- +
1g
97%
1 week
United States
$606
- +
5g
97%
1 week
United States
$1744
- +
Product Description
Catalog Number:
AG00EFK5
Chemical Name:
2-(1H-Imidazol-2-yl)-pyrimidine
CAS Number:
627910-87-6
Molecular Formula:
C7H6N4
Molecular Weight:
146.1493
MDL Number:
MFCD08668966
IUPAC Name:
2-(1H-imidazol-2-yl)pyrimidine
InChI:
InChI=1S/C7H6N4/c1-2-8-6(9-3-1)7-10-4-5-11-7/h1-5H,(H,10,11)
InChI Key:
FKTSKGMJQQGFHN-UHFFFAOYSA-N
SMILES:
c1cnc(nc1)c1ncc[nH]1
Properties
Complexity:
122  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
146.059g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
146.153g/mol
Monoisotopic Mass:
146.059g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
54.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0
Literature
Title Journal
Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway. PloS one 20120101
Identification of a novel allosteric binding site in the CXCR2 chemokine receptor. Molecular pharmacology 20111201
Discovery of a novel series of inhibitors of human cytomegalovirus primase. Bioorganic & medicinal chemistry letters 20060915
Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists. Bioorganic & medicinal chemistry letters 20060515
Construction of 4D-QSAR models for use in the design of novel p38-MAPK inhibitors. Journal of computer-aided molecular design 20050601
p38/SAPK2 controls gap junction closure in astrocytes. Glia 20040501
Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorganic & medicinal chemistry letters 20011105
Properties